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Sir, We thank Dr Bramsen for her interest in our recently
published article (de Lange et al. 2008). In this article, we
report on an increase in prefrontal grey matter volume
following cognitive behavioural therapy (CBT) in a group of
patients suffering from the chronic fatigue syndrome (CFS).
Dr Bramsen raises two points of criticism. First, she
questions the lack of a control group of patients receiving
no treatment or a different treatment. While this limitation
was already emphasized in the discussion section of de
Lange et al. (2008), it remains unclear how the observed
behavioral and cerebral changes could be accounted for by
generic and CBT-independent factors. Dr Bramsen wonders
whether the reported behavioural improvements are really
the result of CBT, or whether they could be due to natural
course or lifestyle changes, while the underlying disease
process is not influenced by CBT. A large body of evidence
suggests that this is not the case: there is overwhelming
evidence in the literature from several carefully conducted
randomized controlled trials (RCT) that demonstrate the
specific efficacy of CBT for CFS (e.g. Sharpe et al. 1996;
Deale et al. 1997; Prins et al. 2001). It was beyond the scope
of this study to disprove that treatments other than CBT
would have resulted in the same—or even better—results,
simply because this possibility has already been tested and
rejected (Whiting et al. 2001; Chambers et al. 2006).
The second point of criticism raised is that the structural
changes in the brain are small, comprising51% of the total
brain volume. Dr Bramsen argues that, although statistically
significant, these changes are unlikely to be clinically
relevant. This argument is more an intuition than a
scientific argument. Given the limited knowledge of
structural plasticity in the adult human brain, it seems
arbitrary to set an a priori threshold for clinical relevance.
More importantly however, Dr Bramsen neglects the fact
that the reported increase in grey matter volume was largely
regionally specific, confined to left and right lateral
prefrontal cortex [see Fig. 3 of de Lange et al. (2008)].
The increase in grey matter volume might appear
numerically modest when expressed in terms of whole-
brain grey matter volume. Yet, when relating the change to
a more specific anatomical structure (the lateral prefrontal
cortex), the increase in grey matter volume was on average
8%. Nevertheless, we prefer to focus on whole-brain grey
matter volume as a dependent measure, as it is a reliable,
sensitive and unbiased measure of overall cerebral mor-
phology (Good et al. 2001; Chard et al. 2002).
In summary, while our study did not compare the
efficacy of CBT in bringing about the behavioural and brain
changes with other treatments or no treatment, there is an
overwhelming amount of evidence from the literature that
shows the specific efficacy of CBT. The size of the structural
changes should naturally be interpreted in relation to the
dependent measure used. Finally, we agree with Dr
Bramsen that our results do open a wide array of new
questions, like: ‘What is the long-term time course of these
structural brain changes?’ and ‘Can successful CBT also lead
to structural brain changes in other psychopathologies, e.g.
depression?’ These exciting research questions will hopefully
be the topic of future studies.
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